WSGR logoWSGR logo
WSGR logo
  • Experience
  • People
  • Insights
  • About Us
  • Careers

  • Practice Areas
  • Industries

  • Corporate
  • Intellectual Property
  • Litigation
  • Patents and Innovations
  • Regulatory
  • Technology Transactions

  • Capital Markets
  • Corporate Governance
  • Corporate Life Sciences
  • Derivatives
  • Emerging Companies and Venture Capital
  • Employee Benefits and Compensation
  • Energy and Climate Solutions
  • Executive Advisory Program
  • Finance and Structured Finance
  • Fund Formation
  • Greater China
  • Mergers & Acquisitions
  • Private Equity
  • Public Company Representation
  • Real Estate
  • Restructuring
  • Shareholder Engagement and Activism
  • Tax
  • U.S. Expansion
  • Wealthtech

  • Special Purpose Acquisition Companies (SPACs)

  • Environmental, Social, and Governance

  • AI and Data Center Infrastructure
  • Energy Regulation and Competition
  • Project Development and M&A
  • Project Finance and Tax Credit Transactions
  • Sustainability and Decarbonization
  • Transportation Electrification

  • U.S. Expansion Library and Resources

  • Post-Grant Review
  • Trademark and Advertising

  • Antitrust Litigation
  • Arbitration
  • Board and Internal Investigations
  • Class Action Litigation
  • Commercial Litigation
  • Consumer Litigation
  • Corporate Governance Litigation
  • Employment Litigation
  • Executive Branch Updates
  • Government Investigations
  • Internet Strategy and Litigation
  • Patent Litigation
  • Securities Litigation
  • State Attorneys General
  • Supreme Court and Appellate Practice
  • Trade Secret Litigation
  • Trademark and Copyright Litigation
  • Trial
  • White Collar Crime

  • Advertising, Promotions, and Marketing
  • Antitrust and Competition
  • Committee on Foreign Investment in the U.S. (CFIUS)
  • Communications
  • Data, Privacy, and Cybersecurity
  • Export Control and Sanctions
  • FCPA and Anti-Corruption
  • FDA Regulatory, Healthcare, and Consumer Products
  • Federal Trade Commission
  • Fintech and Financial Services
  • Government Contracts
  • National Security and Trade
  • Payments
  • State Attorneys General
  • Strategic Risk and Crisis Management
  • Tariffs, Customs, and Import Compliance

  • Antitrust and Intellectual Property
  • Antitrust Civil Enforcement
  • Antitrust Compliance and Business Strategy
  • Antitrust Criminal Enforcement
  • Antitrust Litigation
  • Antitrust Merger Clearance
  • European Competition Law
  • Third-Party Merger and Non-Merger Antitrust Representation

  • Anti-Money Laundering
  • Foreign Ownership, Control, or Influence (FOCI)
  • Team Telecom

  • AI in Healthcare
  • Animal Health
  • Artificial Intelligence and Machine Learning
  • Aviation
  • Biotech
  • Blockchain and Cryptocurrency
  • Clean Energy
  • Climate and Clean Technologies
  • Communications and Networking
  • Consumer Products and Services
  • Data Storage and Cloud
  • Defense Tech
  • Diagnostics, Life Science Tools, and Deep Tech
  • Digital Health
  • Digital Media and Entertainment
  • Electronic Gaming
  • Fintech and Financial Services
  • FoodTech and AgTech
  • Global Generics
  • Internet
  • Life Sciences
  • Medical Devices
  • Mobile Devices
  • Mobility
  • NewSpace
  • Quantum Computing
  • Semiconductors
  • Software

  • Offices
  • Country Desks
  • Events
  • Community
  • Our Diversity
  • Sustainability
  • Our Values
  • Board of Directors
  • Management Team

  • Austin
  • Boston
  • Boulder
  • Brussels
  • Century City
  • Hong Kong
  • London
  • Los Angeles
  • New York
  • Palo Alto
  • Salt Lake City
  • San Diego
  • San Francisco
  • Seattle
  • Shanghai
  • Washington, D.C.
  • Wilmington, DE

  • Law Students
  • Judicial Clerks
  • Experienced Attorneys
  • Patent Agents
  • Business Professionals
  • Alternative Legal Careers
  • Contact Recruiting
Dan Gil
Associate
Patents and Innovations
Boulder
dgil@wsgr.com

D202-791-8005

Download vCard
Open PDF

Dr. Dan Gil is an associate at Wilson Sonsini Goodrich & Rosati. He focuses on strategic intellectual property counseling for various fields, including biomarker discovery, drug discovery, algorithms, high-performance computing, and chemical and materials engineering.

Prior to joining the firm, Dan was a postdoctoral researcher at the University of Chicago in Professor Juan de Pablo’s group, researching polymer reactions and polymer dynamics using generative artificial intelligence algorithms.

Dan obtained his Ph.D. from Case Western Reserve University while studying with Professor Daniel J. Lacks, where he applied computational chemistry (e.g., molecular dynamics and quantum chemistry) to study the science of contact in various contexts, including contact electrification, ionic liquids at electrochemical interfaces, single-stranded DNA brushes on surfaces, and surfaces of complex liquids.

Experience

Dr. Dan Gil is an associate at Wilson Sonsini Goodrich & Rosati. He focuses on strategic intellectual property counseling for various fields, including biomarker discovery, drug discovery, algorithms, high-performance computing, and chemical and materials engineering.

Prior to joining the firm, Dan was a postdoctoral researcher at the University of Chicago in Professor Juan de Pablo’s group, researching polymer reactions and polymer dynamics using generative artificial intelligence algorithms.

Dan obtained his Ph.D. from Case Western Reserve University while studying with Professor Daniel J. Lacks, where he applied computational chemistry (e.g., molecular dynamics and quantum chemistry) to study the science of contact in various contexts, including contact electrification, ionic liquids at electrochemical interfaces, single-stranded DNA brushes on surfaces, and surfaces of complex liquids.

Education
  • J.D., Georgetown University Law Center
  • Ph.D., Chemical Engineering, Case Western Reserve University
  • B.S., Chemical Engineering, Case Western Reserve University
Admissions
  • State Bar of Colorado
  • U.S. Patent and Trademark Office
Credentials
Education
  • J.D., Georgetown University Law Center
  • Ph.D., Chemical Engineering, Case Western Reserve University
  • B.S., Chemical Engineering, Case Western Reserve University
Admissions
  • State Bar of Colorado
  • U.S. Patent and Trademark Office

Select Publications

  • Co-author with M.A. Webb, N.E. Jackson, and J. J. de Pablo, "Targeted sequence design within the coarse-grained polymer genome," Sci. Adv., 2020
  • Co-author with D. J. Lacks, "Humidity transforms immobile surface charges into mobile charges during triboelectric charging," Phys. Chem. Chem. Phys., 2019
  • Co-author with S.J. Jorgenson, A.A. Riet, and D.J. Lacks, "Relationships between molecular structure, interfacial structure, and dynamics of ionic liquids near neutral and charged surfaces," J. Phys. Chem. C, 2018
  • Co-author with D.J. Lacks, P. Parisse, L. Casalis, and M.D. Nkoua Ngavouka, "Single-stranded DNA oligomer brush structure is dominated by intramolecular interactions mediated by the ion environment," Soft Matter, 2018
  • Co-author with A.E. Wang, M. Holonga, Z. Yavuz, H.T. Baytekin, R.M. Sankaran, and D.J. Lacks, "Dependence of triboelectric charging behavior on material microstructure," Phys. Rev. Mat., 2017
  • Co-author with L. Han, D. Iguchi, T.R. Heyl, V.M. Sedwick, C.R. Arza, S. Ohashi, D.J. Lacks, and H. Ishida, "Oxazine ring-related vibrational modes of benzoxazine monomers using fully aromatically substituted, deuterated, 15N isotope exchanged, and oxazine-ring-substituted compounds and theoretical calculations," J. Phys. Chem. A, 2017
  • Co-author with D.J. Lacks, "Effect of surfactant shape on solvophobicity and surface activity in alcohol-water systems," J. Chem. Phys., 2016
  • Co-author with D. J. Lacks, "Geometric origins of surfactant effectiveness in mixed solvent systems," J. Phys. Chem. C, 2015
  • Co-author with A.N. Htet and D. J. Lacks, "Surface activity of octanoic acid in ethanol-water solutions from molecular simulation and experiment," J. Chem. Phys., 2015
Insights

Select Publications

  • Co-author with M.A. Webb, N.E. Jackson, and J. J. de Pablo, "Targeted sequence design within the coarse-grained polymer genome," Sci. Adv., 2020
  • Co-author with D. J. Lacks, "Humidity transforms immobile surface charges into mobile charges during triboelectric charging," Phys. Chem. Chem. Phys., 2019
  • Co-author with S.J. Jorgenson, A.A. Riet, and D.J. Lacks, "Relationships between molecular structure, interfacial structure, and dynamics of ionic liquids near neutral and charged surfaces," J. Phys. Chem. C, 2018
  • Co-author with D.J. Lacks, P. Parisse, L. Casalis, and M.D. Nkoua Ngavouka, "Single-stranded DNA oligomer brush structure is dominated by intramolecular interactions mediated by the ion environment," Soft Matter, 2018
  • Co-author with A.E. Wang, M. Holonga, Z. Yavuz, H.T. Baytekin, R.M. Sankaran, and D.J. Lacks, "Dependence of triboelectric charging behavior on material microstructure," Phys. Rev. Mat., 2017
  • Co-author with L. Han, D. Iguchi, T.R. Heyl, V.M. Sedwick, C.R. Arza, S. Ohashi, D.J. Lacks, and H. Ishida, "Oxazine ring-related vibrational modes of benzoxazine monomers using fully aromatically substituted, deuterated, 15N isotope exchanged, and oxazine-ring-substituted compounds and theoretical calculations," J. Phys. Chem. A, 2017
  • Co-author with D.J. Lacks, "Effect of surfactant shape on solvophobicity and surface activity in alcohol-water systems," J. Chem. Phys., 2016
  • Co-author with D. J. Lacks, "Geometric origins of surfactant effectiveness in mixed solvent systems," J. Phys. Chem. C, 2015
  • Co-author with A.N. Htet and D. J. Lacks, "Surface activity of octanoic acid in ethanol-water solutions from molecular simulation and experiment," J. Chem. Phys., 2015
Focus Areas
  • Artificial Intelligence and Machine Learning
  • Biotech
  • Diagnostics, Life Science Tools, and Deep Tech
  • Intellectual Property
  • Life Sciences
  • Patents and Innovations
Recent Insights
Client Highlights
Wilson Sonsini Advises Iambic Therapeutics on $50 Million Series B Extension, Bringing Total Series B Funding to Over $150 Million
On June 18, 2024, Iambic Therapeutics (Iambic), a clinical-stage biotechnology company developing novel therapeutics from its unique generative AI discovery platform, announced the closing of an oversubscribed $50 million extension, bringing the total Series B funding to over $150 million. The Series B extension was led by new investors Mubadala Capital and Exor Ventures, and existing investors Abingworth, Illumina Ventures, Nexus Venture Partners, Coatue, and Tao Capital Partners. Wilson Sonsini Goodrich & Rosati advised Iambic on the transaction.
Learn More
Client Highlights
Firm Advises Iambic Therapeutics on $100 Million Series B Financing
On October 3, 2023, Iambic Therapeutics, a biotechnology company developing novel therapeutics from its unique generative AI discovery platform, announced the closing of an oversubscribed $100 million Series B financing. The financing was co-led by Ascenta Capital and Abingworth, and included new investors NVIDIA and Illumina Ventures. Existing investors also participated, including Nexus Ventures, Catalio Capital Management, Coatue, FreeFlow, OrbiMed, and Sequoia Capital. Wilson Sonsini Goodrich & Rosati advised Iambic on the transaction.
Learn More
  • people
  • insights
  • about us
  • careers
  • Binder
  • Alumni
  • Mailing List Signup
  • Client FTP Portal
  • Privacy Policy
  • Terms of Use
  • Accessibility
WSGR logo
Twitter
LinkedIn
Facebook
Instagram
Youtube
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.